4//SEC Filing
Townsend Adam J. 4
Accession 0001127602-25-001629
CIK 0001492422other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:12 PM ET
Size
4.6 KB
Accession
0001127602-25-001629
Insider Transaction Report
Form 4
Townsend Adam J.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-01-17$29.96/sh−2,201$65,938→ 88,068 total
Footnotes (1)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001773588
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:12 PM ET
- Size
- 4.6 KB